Physician profile
Brian J Kerr
NPI 1407940190
$3,200.73
in general payments reported to CMS, 2019-2025
9 companies · $74.88 in 2025
The $74.88 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $1,532 · 2022: $27.09 · 2023: $27.15 · 2024: $410 · 2025: $74.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,182.30 | 2019-2024 | Arthrex |
| Smith+Nephew, INC. | $698.86 | 2019-2020 | |
| Lightbody Medical Technologies INC | $130.14 | 2024 | |
| Stryker Corporation | $50.52 | 2025 | System 9 Cd Nxt |
| Linvatec Corporation | $36.95 | 2022-2024 | Conmed 3dhd Video Systems, Linvatec Video Accessories |
| Embody, INC. | $35.31 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $31.23 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Radius Health, INC. | $24.36 | 2025 | Tymlos |
| Sunovion Pharmaceuticals INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.